IDEX Corporation provides applied solutions through its subsidiaries in the United States, North America, Europe, Asia, and internationally. It operates in three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes precision fluidics, pumps, processing technologies, sealing solutions, medical devices, optical components, and other engineered products. The FMT segment focuses on positive displacement pumps, valves, flow meters, and fluid-handling systems, while the FSDP segment offers firefighting equipment, rescue tools, and precision dispensing and mixing equipment. The company was incorporated in 1987 and is headquartered in Northbrook, Illinois.
IDEX Lifts 2026 Organic Sales Growth Forecast to 5-6% on Strong HST Orders
IDEX Corporation has raised its 2026 organic sales growth forecast to 5-6% from a previous range of 3-4%, citing a stronger order backlog in its Health & Science Technologies segment and improving demand in its industrial operations. In the second quarter of 2026, the HST segment's organic sales rose 12% and organic orders climbed 47%, extending backlog visibility into 2027, while the Fluid & Metering Technologies segment posted a 1% increase in organic sales and an 11% rise in orders on solid municipal water and mining demand. Acquisitions added 1% to consolidated sales growth and 2% to HST sales growth in the quarter, reflecting the July 2025 purchase of Micro-LAM, which expanded IDEX's materials science and optics capabilities across aerospace and defense. The company returned $106.7 million in dividends and $153.4 million in share repurchases in the first six months of 2026, and its board increased the share repurchase authorization to $1 billion in September 2025, leaving $774.7 million available at the end of the second quarter. The Zacks Consensus Estimate for IDEX's 2026 earnings stands at $8.83 per share, up 11.1% year over year, with 2027 earnings projected at $9.64 per share, up 9.2%.
SPX Technologies Leads Gas and Liquid Handling Stocks in Q2 Earnings
SPX Technologies reported second-quarter revenues of $679 million, up 22.9% year over year and beating analysts' expectations by 5.8%, making it the best performer among the 11 gas and liquid handling stocks tracked. The company also achieved the highest full-year guidance raise among its peers, and its stock has risen 12.2% since reporting to trade at $223.54. Parker-Hannifin posted revenues of $5.76 billion, up 9.8% year over year and exceeding estimates by 3.3%, with full-year EPS guidance also beating expectations. Graco was the slowest performer, with revenues of $590.6 million, up 3.3% year over year but missing estimates by 3%. Flowserve reported revenues of $1.17 billion, down 1.6% year over year but topping estimates by 0.9%, while IDEX posted revenues of $920.6 million, up 6.4% year over year and beating estimates by 1.7%.
IDEX shares rise 28.7% year to date as earnings and buyback fuel valuation debate
IDEX Corporation released second quarter and first half 2026 results and updated its share repurchase program, with the stock trading at US$230.45 and up 28.7% year to date. The most followed narrative on Simply Wall St places fair value at US$248 per share, suggesting the stock is 7.1% undervalued, driven by international expansion and technology adaptation in markets like pharmaceuticals and data centers. However, the current price-to-earnings ratio of 32.7x exceeds the fair ratio of 27.1x and the US Machinery industry average of 27.3x, indicating investors are already paying a premium. Bulls point to growing sales, earnings, and the buyback as signs of further upside, while bears highlight the higher starting price and risks including tariff-related cost pressure and softer demand in semiconductors and agriculture.
IEX · Capital · Neutral Earnings and buyback fuel valuation debate; stock up 28.7% YTD but P/E premium and tariff/semiconductor risks create mixed outlook.
Idex earnings expected to grow but Zacks model signals no clear beat
Idex is expected to report quarterly earnings of $2.10 per share on revenues of $902.43 million for the quarter ended June 2026, representing year-over-year growth of 1.5% and 4.3% respectively. The Zacks Earnings ESP for Idex stands at -0.67% with a Zacks Rank of #3, making it difficult to conclusively predict an earnings beat. Over the last four quarters, the company has beaten consensus EPS estimates each time. In the same industry, Crane is expected to post earnings of $1.66 per share on revenues of $706.06 million, with a positive Earnings ESP of +4.73% and a Zacks Rank of #2, suggesting a likely beat.
IEX · Capital · Neutral The article discusses Idex's upcoming earnings expectations and the Zacks model's inability to predict a clear beat, with no definitive positive or negative news.
CR · Capital · Neutral Crane is mentioned as a peer in the same industry with a positive Earnings ESP, suggesting a likely earnings beat, but the article focuses on Idex.
StockStory Picks Natera as Cash-Producing Stock with Exciting Potential, Brushes Off Domino’s and IDEX
StockStory highlights Natera as a cash-producing stock with exciting potential, while advising investors to avoid Domino’s and IDEX. Natera, which develops genetic tests, saw tests processed grow 19.4% annually over two years, its adjusted operating margin expand by 15.7 percentage points, and free cash flow turn positive over five years. Domino’s is flagged for soft sales growth of 5.2% over seven years and an estimated 5.9% for the next 12 months, trading at 15.3 times forward earnings. IDEX is criticized for underperforming organic revenue, annual EPS growth of just 1.2% over two years, and eroding returns on capital, with shares at 25.2 times forward earnings.
StockStory flags IDEX, Flex, and MSCI as profitable but risky stocks
StockStory identifies IDEX, Flex, and MSCI as profitable companies that warrant caution due to weakening fundamentals. IDEX, with a 20.7% trailing operating margin, has seen no organic revenue growth over two years and earnings per share rising only 1.2% annually. Flex, at a 4.9% margin, posted just 2.8% annual revenue growth and a weak 2.8% free cash flow margin over five years. MSCI, despite a 55.4% margin, shows negative return on equity. The report suggests better opportunities exist elsewhere.
IDEX Corporation Stock Outperforms Industrial ETF Over Three Months and Year to Date
IDEX Corporation shares have risen 18.3% over the past three months, more than double the 9.5% gain of the State Street Industrial Select Sector SPDR ETF. The stock is up 26.4% year to date, exceeding the ETF's 16.6% advance, and has gained 28.5% over the past 52 weeks compared to the ETF's 27.2% return. Shares jumped 5.8% on April 29 after the company reported first-quarter 2026 sales of $887 million and adjusted diluted earnings per share of $2, both above expectations, and raised its full-year organic sales growth guidance to 3% to 4% and adjusted EPS guidance to $8.35 to $8.55. Rival Eaton Corporation plc has returned 32.4% year to date, outpacing IDEX, but its 52-week return of nearly 26% trails IDEX's performance. Analysts have a consensus Moderate Buy rating on IDEX with a mean price target of $241.23, a 7.2% premium to current levels.
IDEX declared a regular quarterly cash dividend of $0.73 per share, matching the previous payout. The dividend is payable on July 24 to shareholders of record as of July 6, with an ex-dividend date of July 6. The forward yield is 1.31 percent. This marks the second consecutive quarter that the company has announced a dividend of $0.73.
United States